The bank upgraded the pharmacy stock to buy from hold and reiterated a $66 per share price target. Analyst George Hill said that CVS' earnings and multiple are likely near trough levels and highlighted the company's efforts to foster growth — including recent leadership changes. CVS YTD mountain CVS stock. The company is coming off of mixed third-quarter results where CVS did not provide forward guidance. CVS stock has pulled back more than 25% in 2024.

---

Persons: Banks, George Hill, Hill, David Joyner —, Karen Lynch Organizations: CVS, Deutsche Locations: Monday's